MXPA01013302A - Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas. - Google Patents
Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas.Info
- Publication number
- MXPA01013302A MXPA01013302A MXPA01013302A MXPA01013302A MXPA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A
- Authority
- MX
- Mexico
- Prior art keywords
- piv
- human
- bovine
- genome
- chimeric
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000002606 Paramyxoviridae Infections Diseases 0.000 title abstract 2
- 101150034575 piv gene Proteins 0.000 abstract 18
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 241000283690 Bos taurus Species 0.000 abstract 4
- 239000013598 vector Substances 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 108020001580 protein domains Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14313499P | 1999-07-09 | 1999-07-09 | |
| PCT/US2000/017066 WO2001004320A1 (en) | 1999-07-09 | 2000-06-16 | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01013302A true MXPA01013302A (es) | 2004-03-10 |
Family
ID=22502741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01013302A MXPA01013302A (es) | 1999-07-09 | 2000-06-16 | Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas. |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP1194564B1 (enExample) |
| JP (1) | JP4813711B2 (enExample) |
| KR (1) | KR100940776B1 (enExample) |
| CN (2) | CN101392239A (enExample) |
| AT (1) | ATE408693T1 (enExample) |
| BR (1) | BR0013190A (enExample) |
| CA (1) | CA2378661A1 (enExample) |
| DE (1) | DE60040289D1 (enExample) |
| ES (1) | ES2312347T3 (enExample) |
| IL (2) | IL147167A0 (enExample) |
| MX (1) | MXPA01013302A (enExample) |
| WO (1) | WO2001004320A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192593B2 (en) | 1997-05-23 | 2007-03-20 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| EP1179054A2 (en) * | 1999-12-10 | 2002-02-13 | The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services | Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| US6764685B1 (en) * | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| WO2002002605A2 (en) * | 2000-07-05 | 2002-01-10 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| DK1351981T3 (da) | 2001-01-19 | 2012-11-26 | Vironovative Bv | Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr |
| US8715922B2 (en) | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| ATE509097T1 (de) | 2001-11-21 | 2011-05-15 | Us Health | Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna |
| TWI344991B (en) | 2002-02-21 | 2011-07-11 | Medimmune Vaccines Inc | Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences |
| US7820181B2 (en) | 2002-09-18 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| JP2007524372A (ja) | 2003-02-28 | 2007-08-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 組換えヒトメタニューモウイルスおよびその使用 |
| CN101410519B (zh) | 2003-04-25 | 2013-04-24 | 免疫医疗有限责任公司 | 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法 |
| CA2523657A1 (en) * | 2003-04-25 | 2005-03-31 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| WO2004113517A2 (en) | 2003-06-09 | 2004-12-29 | Wyeth | IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| CN107818197B (zh) * | 2017-09-15 | 2021-05-25 | 南京航空航天大学 | 一种基于piv技术的超声速翼型的测力方法和装置 |
| GB201816873D0 (en) * | 2018-10-17 | 2018-11-28 | Imperial Innovations Ltd | Fusion protein |
| CN113322241B (zh) * | 2021-05-14 | 2023-06-13 | 金宇保灵生物药品有限公司 | 一种牛副流感病毒3型病毒株bpiv3-nm及其应用 |
| CN116676275B (zh) * | 2023-03-17 | 2024-06-07 | 北京赛尔富森生物科技有限公司 | A基因型嵌合腮腺炎病毒株和制备方法及用途 |
| AU2024380679A1 (en) | 2023-11-17 | 2026-07-02 | Sanofi Vaccines US Inc. | Trehalose vaccine formulation |
| CN118909958B (zh) * | 2024-07-25 | 2025-02-07 | 中国兽医药品监察所 | 一株牛副流感病毒3型np蛋白杂交瘤细胞株及单抗和在检测抗原中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| EP0780475B2 (en) | 1995-08-09 | 2006-07-19 | SCHWEIZ. SERUM- & IMPFINSTITUT BERN | Process for the production of infectious negative-strand RNA viruses |
| US6165774A (en) * | 1995-09-22 | 2000-12-26 | Connaught Laboratories Limited | Parainfluenza virus glycoproteins and vaccines |
| US5869036A (en) * | 1995-12-08 | 1999-02-09 | St. Louis University | Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| DE69842165D1 (de) * | 1997-05-23 | 2011-04-21 | Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services | Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen |
-
2000
- 2000-06-15 CA CA002378661A patent/CA2378661A1/en not_active Abandoned
- 2000-06-15 KR KR1020027000325A patent/KR100940776B1/ko not_active Expired - Fee Related
- 2000-06-15 CN CNA2008100985262A patent/CN101392239A/zh active Pending
- 2000-06-16 EP EP00941614A patent/EP1194564B1/en not_active Expired - Lifetime
- 2000-06-16 IL IL14716700A patent/IL147167A0/xx unknown
- 2000-06-16 DE DE60040289T patent/DE60040289D1/de not_active Expired - Lifetime
- 2000-06-16 BR BR0013190-3A patent/BR0013190A/pt not_active Application Discontinuation
- 2000-06-16 AT AT00941614T patent/ATE408693T1/de not_active IP Right Cessation
- 2000-06-16 CN CNB008101205A patent/CN100402651C/zh not_active Expired - Fee Related
- 2000-06-16 WO PCT/US2000/017066 patent/WO2001004320A1/en not_active Ceased
- 2000-06-16 EP EP08164459A patent/EP2019140A3/en not_active Withdrawn
- 2000-06-16 MX MXPA01013302A patent/MXPA01013302A/es active IP Right Grant
- 2000-06-16 EP EP08164460A patent/EP2019141A3/en not_active Withdrawn
- 2000-06-16 JP JP2001509524A patent/JP4813711B2/ja not_active Expired - Fee Related
- 2000-06-16 ES ES00941614T patent/ES2312347T3/es not_active Expired - Lifetime
-
2001
- 2001-12-18 IL IL147167A patent/IL147167A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL147167A (en) | 2010-06-16 |
| WO2001004320A1 (en) | 2001-01-18 |
| KR100940776B1 (ko) | 2010-02-11 |
| EP2019140A2 (en) | 2009-01-28 |
| EP1194564A1 (en) | 2002-04-10 |
| EP2019141A2 (en) | 2009-01-28 |
| CN100402651C (zh) | 2008-07-16 |
| JP2003504064A (ja) | 2003-02-04 |
| JP4813711B2 (ja) | 2011-11-09 |
| IL147167A0 (en) | 2002-08-14 |
| CN1369011A (zh) | 2002-09-11 |
| KR20020022768A (ko) | 2002-03-27 |
| DE60040289D1 (de) | 2008-10-30 |
| EP2019140A3 (en) | 2009-02-04 |
| ATE408693T1 (de) | 2008-10-15 |
| EP1194564B1 (en) | 2008-09-17 |
| BR0013190A (pt) | 2002-07-16 |
| EP2019141A3 (en) | 2009-02-04 |
| CA2378661A1 (en) | 2001-01-18 |
| CN101392239A (zh) | 2009-03-25 |
| ES2312347T3 (es) | 2009-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE419369T1 (de) | Chimäre mensch-rinder respiratory syncytial virus vakzinen | |
| WO2001042445A3 (en) | USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS | |
| Lu et al. | A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike | |
| ATE85622T1 (de) | Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus. | |
| AU2013322635B2 (en) | Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications | |
| DE60139026D1 (de) | Lebender influenza impfstoff und verfahren zu seiner herstellung | |
| CA2230033A1 (en) | Production of infectious respiratory syncytial virus from cloned nucleotide sequences | |
| HU229101B1 (en) | Dna transfection system for the generation of infectious influenza virus | |
| IL147167A0 (en) | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines | |
| NO904538L (no) | Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3. | |
| JP2014507146A5 (enExample) | ||
| WO2004027037A3 (en) | RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS | |
| Herlocher et al. | Molecular and biological changes in the cold-adapted" master strain" A/AA/6/60 (H2N2) influenza virus. | |
| Operschall et al. | Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice | |
| WO2003043587A3 (en) | Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna | |
| JP2000512263A (ja) | インフルエンザワクチン | |
| WO2002002605A3 (en) | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines | |
| KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
| ATE307606T1 (de) | Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung | |
| DE60136811D1 (de) | Respiratorische synzytialvirus impfstoffe, welche schützende antigene von promotor-proximalen genen exprimieren | |
| Park et al. | Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory syncytial virus | |
| BR0105530A (pt) | Vìrus da parainfluenza, métodos para estimular o sistema imune de um paciente para induzir proteção contra o vìrus da parainfluenza e para produzir uma partìcula de vìrus da parainfluenza, método de imunização sequencial para estimular o sistema imune de um paciente a induzir proteção contra patógenos múltiplos, composição imunogênica para evocar uma resposta imune contra o virus da parainfluenza, polinucleotìdeo isolado e vetor de expressão | |
| Truyen et al. | Studies on linear epitopes of Semliki Forest virus in protection studies against lethal challenge virus infection | |
| Knowles | A comparison of the pathogenesis of human adenovirus type 5 with that of a human adenovirus type 5 recombinant containing the rabies glycoprotein gene in mice. | |
| Vorobyeva et al. | Comparative study of inactivated culture vaccines against tick-borne encephalitis produced in Russia and Austria (Immuno) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |